awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38931842-CBAC37DC-4A0D-47A5-9E22-35F05F7D0DF0
Q38931842-CBAC37DC-4A0D-47A5-9E22-35F05F7D0DF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38931842-CBAC37DC-4A0D-47A5-9E22-35F05F7D0DF0
SGLT2 Inhibitors: Benefit/Risk Balance.
P2860
Q38931842-CBAC37DC-4A0D-47A5-9E22-35F05F7D0DF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38931842-CBAC37DC-4A0D-47A5-9E22-35F05F7D0DF0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c2e241a4b562041e8f302908296d504f2af94299
P2860
Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.